Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

INSYS Therapeutics- Inc. (INSY)

7.92 -0.23 (-2.82%)

06-25 10:06

Open:

8.05

Pre. Close:

8.15

High:

8.07

Low:

7.851

Volume:

147,690

Market Cap:

585M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.485 - 8.528

8.528 - 8.561

Low:

7.932 - 7.976

7.976 - 8.01

Close:

8.08 - 8.154

8.154 - 8.211

Technical analysis  (as of: 2018-06-22 4:31:48 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 10.38     One year: 12.13

Support:

Support1: 7.36    Support2: 6.42

Resistance:

Resistance1: 8.89    Resistance2: 10.38

Pivot:

7.48

Moving Averages:

MA(5): 8.09     MA(20): 7.29

MA(100): 7.14     MA(250): 8.10

MACD:

MACD(12,26): 0.36     Signal(12,26,9): 0.23

%K %D:

%K(14,3): 74.72     %D(3): 69.31

RSI:

RSI(14): 61.77

52-Week:

High: 14  Low: 4.1  Change(%): -38.4

Average Vol(K):

3-Month: 67499  10-Days 133570

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
INSY has closed below upper band by 22.0%. Bollinger Bands are 50.1% wider than normal. The large width of the bands suggest high volatility as compared to INSY's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

2018-06-23T05:01:00-04:00
Johnson Fistel Announces Investigations of Veevo Instruments Inc., Insys Therapeutics, Inc., TAL Education Group and Newell Brands Inc.; Investors Encouraged to Contact Firm

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

73.81

Shares Float (M)

73.18

% Held by Insiders

% Held by Institutions

69.50

Shares Short (K)

10562

Shares Short Prior Month (K)

10710

Stock Financials

EPS

-0.710

EPS Est. Current Year

-0.330

EPS Est. Next Year

-0.190

EPS Est. Next Quarter

-0.120

Forward EPS

-0.070

Book Value (p.s.)

12.620

PEG Ratio

-0.43

Profit Margin

Operating Margin

-51.72

Return on Assets (ttm)

-75.0

Return on Equity (ttm)

-135.4

Qtrly Rev. Growth

-33.5

Gross Profit (p.s.)

0.838

Sales Per Share

EBITDA (p.s.)

-2.470

Qtrly Earnings Growth

Operating Cash Flow (M)

-61.40

Levered Free Cash Flow (M)

90.95

atoplab.com

Valuation

P/E

-11.48

P/E Growth Ratio

-0.03

P/BV

0.65

P/S

339859584.00

P/CF

-9.80

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2015-06-08

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.